Vaccination

Moderna sues Pfizer, BioNTech over COVID vaccine

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their COVID-19 shot administered to hundreds of millions around the world.

Vaccination

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives—a key step toward opening a fall booster campaign.

Diseases, Conditions, Syndromes

EU eyes autumn approval of Pfizer jab for COVID variants

The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech COVID vaccine adapted for two fast-spreading subvariants of the Omicron strain.

Other

Pfizer in talks on $5 billion acquisition: media

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

Diseases, Conditions, Syndromes

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works—just days before regulators debate whether to offer Americans updated booster shots this fall.

page 6 from 40